ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 57 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $1,351,000 | +61.6% | 628,400 | +72.2% | 0.72% | +57.0% |
Q4 2014 | $836,000 | -90.3% | 365,000 | -64.7% | 0.46% | -92.4% |
Q4 2013 | $8,616,000 | -0.4% | 1,033,100 | +10.7% | 6.02% | +40.6% |
Q3 2013 | $8,650,000 | -5.4% | 933,100 | 0.0% | 4.28% | +18.9% |
Q2 2013 | $9,144,000 | – | 933,100 | – | 3.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 1,368,500 | $3,134,000 | 0.61% |
TANG CAPITAL MANAGEMENT LLC | 365,000 | $836,000 | 0.46% |
Abingworth LLP | 603,740 | $1,352,000 | 0.38% |
Cheyne Capital Management (UK) LLP | 150,000 | $338,000 | 0.09% |
Telemetry Investments, L.L.C. | 50,000 | $114,000 | 0.07% |
Rotella Capital Management, Inc. | 19,473 | $45,000 | 0.04% |
SABBY MANAGEMENT, LLC | 461,957 | $1,058,000 | 0.03% |
Nine Chapters Capital Management LLC | 113,700 | $260,000 | 0.02% |
STONERIDGE INVESTMENT PARTNERS LLC | 49,471 | $113,000 | 0.02% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 87,388 | $200,000 | 0.01% |